Dr. Reddy's Lab gets EIR from USFDA for Miryalaguda plant

31 May 2019 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for API manufacturing plant at Miryalaguda (Nalgonda District) indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI). Earlier, USFDA had conducted audit at Miryalaguda plant on January 28, 2019.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1209.45 1.95 (0.16%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×